Biotech ETF Overview

No one U.S. biotech ETFs provides comprehensive, unbiased access to the space. Instead, each captures a piece of it—and of related industries like pharmaceuticals and medical. Tread carefully here, as each fund defines biotech differently, and the differences have material impacts on performance: In some years, the difference between the best-performing and the worst-performing biotech ETF exceeds 15%. The good news is that most of these biotech ETFs are relatively efficient and liquid.

Daily ETF Flows

S&P 500 ETFs Pull In $7.3 Billion

S&P 500 Index ETFs from State Street, iShares and Vanguard pulled in a total of $7.3 billion on Tuesday.

Features and News

Why Health Care Is The Top Sector Of 2017

Health care ETFs have largely shrugged off the Republican health care bill.

Daily Hot Reads

Monday Hot Reads: The Future Of ETFs

Also, Morningstar to offer mutual funds for exclusive use of advisors.

Weekly ETF Flows

Weekly ETF Inflow Streak Since Election Continues

The post-election surge of inflows into ETFs slowed this week, but the winning streak continued.

Features and News

February ETF Flows Point To Passive Opportunity

Cheap vanilla funds are missing from many ETF segments, which present new opportunity.

Daily Hot Reads

Thursday Hot Reads: ETFs Causing Market To Spike At End Of Day

Also, financial ETF hits highest level since 2007.

Daily Hot Reads

Friday Hot Reads: BlackRock Backs Gold To Hedge Market Risk

Also, biotech ETF on the brink of a breakout.

Daily Hot Reads

Monday Hot Reads: An ETF Way To Play Trump's Wall

Also, key economic events in the coming big week for the U.S.

Features and News

Thursday Hot Reads: 3 ETF Trends For 2017

Also, why raising rates can push PowerShares' dollar ETF even higher.